BMGL
Basel Medical·NASDAQ
--
--(--)
--
--(--)
2.28 / 10
Underperform
Evaluation yields 2.3/10, reflecting inadequate financial health. Key positives: Net profit attributable to parent company shareholders (YoY growth rate %) and Basic earnings per share (YoY growth rate %), balanced by issues in Net cash flow from operating activities per share (YoY growth rate %) and Net cash flow from operating activities (YoY growth rate %). This configuration appears prudent.
Analysis Checks(3/6)
Net cash flow from operating activities per share (YoY growth rate %)
Value-25.27
Score1/3
Weight10.92%
1M Return1.22%
Value-25.27
Score1/3
Weight10.92%
1M Return1.22%
Total profit (YoY growth rate %)
Value-620.07
Score1/3
Weight14.26%
1M Return1.57%
Value-620.07
Score1/3
Weight14.26%
1M Return1.57%
Diluted earnings per share (YoY growth rate %)
Value-594.62
Score2/3
Weight20.84%
1M Return2.41%
Value-594.62
Score2/3
Weight20.84%
1M Return2.41%
Basic earnings per share (YoY growth rate %)
Value-594.62
Score2/3
Weight24.54%
1M Return2.78%
Value-594.62
Score2/3
Weight24.54%
1M Return2.78%
Net cash flow from operating activities (YoY growth rate %)
Value-273.12
Score1/3
Weight5.08%
1M Return0.62%
Value-273.12
Score1/3
Weight5.08%
1M Return0.62%
Net profit attributable to parent company shareholders (YoY growth rate %)
Value-683.15
Score2/3
Weight24.36%
1M Return2.61%
Value-683.15
Score2/3
Weight24.36%
1M Return2.61%
Net cash flow from operating activities per share (YoY growth rate %)
Value-25.27
Score1/3
Weight10.92%
1M Return1.22%
Value-25.27
Score1/3
Weight10.92%
1M Return1.22%
Basic earnings per share (YoY growth rate %)
Value-594.62
Score2/3
Weight24.54%
1M Return2.78%
Value-594.62
Score2/3
Weight24.54%
1M Return2.78%
Total profit (YoY growth rate %)
Value-620.07
Score1/3
Weight14.26%
1M Return1.57%
Value-620.07
Score1/3
Weight14.26%
1M Return1.57%
Net cash flow from operating activities (YoY growth rate %)
Value-273.12
Score1/3
Weight5.08%
1M Return0.62%
Value-273.12
Score1/3
Weight5.08%
1M Return0.62%
Diluted earnings per share (YoY growth rate %)
Value-594.62
Score2/3
Weight20.84%
1M Return2.41%
Value-594.62
Score2/3
Weight20.84%
1M Return2.41%
Net profit attributable to parent company shareholders (YoY growth rate %)
Value-683.15
Score2/3
Weight24.36%
1M Return2.61%
Value-683.15
Score2/3
Weight24.36%
1M Return2.61%
Is BMGL fundamentally strong?
- BMGL scores 2.28/10 on fundamentals and holds a Premium valuation at present. Backed by its -194.55% ROE, -106.79% net margin, -1.29 P/E ratio, 3.20 P/B ratio, and -627.01% earnings growth, these metrics solidify its Underperform investment rating.
